Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway

Journal of Immunology

Volumn 166, Issue 5, 2001, Pages 3491-3498

  Li, W Q ^a   Dehnade, F ^a   Zafarullah, M ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CURCUMIN; INTERLEUKIN 1; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; JANUS KINASE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; ONCOSTATIN M; PROTEIN TYROSINE KINASE; RNA; STAT PROTEIN; STAT1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CATABOLISM; DNA BINDING; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

EID: 0035284754     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.5.3491     Document Type: Article

References (68)

1. Immunological markers of joint inflammation, skeletal damage and repair: Where are we now?
2. Regulation of matrix metalloproteinase expression in tumor invasion
3. Matrix metalloproteinases
4. Biochemical characterization of human collagenase-3
5. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
6. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase and nuclear factor κB: Differential regulation of collagenase 1 and collagenase 3
7. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes
8. Aggrecan degradation in human cartilage: Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints
9. Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro
10. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium
11. Tissue inhibitors of metalloproteinases: Evolution, structure and function
12. Using inhibitors of metalloproteinases to treat arthritis: Easier said than done?
13. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
14. A new inhibitor of metalloproteinases from chicken: ChIMP-3: A third member of the TIMP family
15. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues
16. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22
17. Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family
18. Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family
19. A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth
20. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
21. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family
22. Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints
23. Oncostatin M: A growth regulator produced by differentiated histiocyte lymphoma cells
24. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro
25. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130
26. Regulation of inflammatory responses by oncostatin M
27. Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis
28. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis
29. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint
30. Oncostatin M induces leukocyte infiltration and cartilage proteoglycan degradation in vivo in goat joints
31. Stimulation of TIMP-1 production by oncostatin M in human articular cartilage
32. Leukemia inhibitoty factor and oncostatin M stimulate collagenase-3 expression in osteoblasts
33. Oncostatin M stimulates monocyte chemoattractant protein-1 and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro
34. Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinase- and mitogen-activated protein kinase-dependent mechanisms
35. Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway
36. STATs: Signal transducers and activators of transcription
37. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
38. Role of tyrosine kinases in induction of the c-jun proto-oncogene in irradiated B-lineage lymphoid cells
39. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
40. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
41. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
42. The chondrocyte, architect of cartilage-biomechanics, structure, function and molecular biology of cartilage matrix macromolecules
43. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase associated activation of gelatinase A, gelatinase B and collagenase 3
44. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
45. Oncostatin M differentially regulates tissue inhibitors of metalloproteinases TIMP-1 and T1MP-3 gene expression in human synovial lining cells
46. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture
47. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases
48. Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity
49. Persistent activation of the STAT1 in rheumatoid synovial fluid cells
50. Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids
51. Jaks and STATs: Biological implications
52. Activation of the JAK-STAT signal transduction pathway by oncostatin-M in cultured human and mouse osteoblastic cells
53. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation
54. How cells respond to inteferons
55. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins
56. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice
57. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound
58. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells
59. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin
60. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloylmethane)
61. Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity
62. Pharmacology of Curcuma longa
63. β interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway
64. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter
65. Oncostatin M stimulates c-fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter
66. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase, gelatinase B
67. Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion
68. Oncostatin M is a proinflammatory mediator: In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules